1. Home
  2. EOS vs MGTX Comparison

EOS vs MGTX Comparison

Compare EOS & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Enhance Equity Income Fund II

EOS

Eaton Vance Enhance Equity Income Fund II

SELL

Current Price

$21.54

Market Cap

1.1B

Sector

Finance

ML Signal

SELL

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

SELL

Current Price

$9.99

Market Cap

1.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EOS
MGTX
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
EOS
MGTX
Price
$21.54
$9.99
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $27.75
AVG Volume (30 Days)
141.1K
★ 1.0M
Earning Date
01-01-0001
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.02
EPS
N/A
★ 1.30
Revenue
N/A
★ $81,391,000.00
Revenue This Year
N/A
$314.19
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$7.98
Revenue Growth
N/A
★ 144.57
52 Week Low
$19.44
$6.62
52 Week High
$24.03
$15.35

Technical Indicators

Market Signals
Indicator
EOS
MGTX
Relative Strength Index (RSI) 53.47 28.24
Support Level $21.17 $8.84
Resistance Level $21.71 $10.71
Average True Range (ATR) 0.22 0.48
MACD 0.04 -0.05
Stochastic Oscillator 75.55 2.99

Price Performance

Historical Comparison
EOS
MGTX

About EOS Eaton Vance Enhance Equity Income Fund II

Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: